A Philadelphia jury has handed up a defense verdict in favor of Bayer and Janssen Pharmaceuticals, finding that the label on the blood thinner Xarelto adequately warned patients about the danger of severe bleeds.

The jury, deliberating in the second Xarelto trial to come before a Philadelphia Court of Common Pleas jury, rendered its verdict Friday morning, after more than two weeks of trial and about two days of deliberation.